Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3651-3657

  Eckert, Randal ^a   He, Jian ^a   Yarbrough, Daniel K ^a   Qi, Fengxia ^a   Anderson, Maxwell H ^b   Shi, Wenyuan ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b C3 Jian Inc   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPETENCE STIMULATING PEPTIDE; PHEROMONE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOFILM; FLUORESCENCE MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; STREPTOCOCCUS GORDONII; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS; TOOTH PLAQUE;

ANTI-BACTERIAL AGENTS; BIOFILMS; DENTAL CARIES; FLUORESCENT DYES; HUMANS; KINETICS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, FLUORESCENCE; PEPTIDES; PHEROMONES; SALIVA; SPECIES SPECIFICITY; STREPTOCOCCUS MUTANS;

EID: 33750584025     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00622-06     Document Type: Article

References (48)

1. Aas, J. A., B. J. Paster, L. N. Stokes, I. Olsen, and F. E. Dewhirst 2005. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43:5721-5732.
2. Ajdic, D., W. M. McShan, R. E. McLaughlin, G. Savic, J. Chang, M. B. Carson, C. Primeaux, R. Tian, S. Kenton, H. Jia, S. Lin, Y. Qian, S. Li, H. Zhu, F. Najar, H. Lai, J. White, B. A. Roe, and J. J. Ferretti. 2002. Genome sequence of Streptococcus mutans UA159, a cariogenjc dental pathogen. Proc. Natl. Acad. Sci. USA 99:14434-14439.
3. Anderson, M. H., and W. Shi. 2006. A probiotic approach to caries management. Pediatr. Dent. 28:151-153.
4. Anonymous. 2002. Infectious diseases-dental caries. Washington State Department of Health, Olympia, Wash.
5. Anonymous. 2000. Oral health in America: a report of the Surgeon General. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md.
6. Axelsson, P., and J. Lindhe. 1987. Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. J. Clin. Periodontol. 14:205-212.
7. Beighton, D. 2005. The complex oral microflora of high-risk individuals and groups and its role in the caries process. Community Dent. Oral Epidemiol. 33:248-255.
8. Blehert, D. S., R. J. Palmer, Jr., J. B. Xavier, J. S. Almeida, and P. E. Kolenbrander. 2003. Autoinducer 2 production by Streptococcus gordonii DL1 and the biofilm phenotype of a luxS mutant are influenced by nutritional conditions. J. Bacteriol. 185:4851-4860.
9. Boman, H. G. 2000. Innate immunity and the normal microflora. Immunol. Rev. 173:5-16.
10. Caufield, P. W., A. P. Dasanayake, Y. Li, Y. Pan, J. Hsu, and J. M. Hardin. 2000. Natural history of Streptococcus sanguinis in the oral cavity of infants: evidence for a discrete window of infectivity. Infect. Immun. 68:4018-4023.
11. Chandler, J. R., and G. M. Dunny. 2004. Enterococcal peptide sex pheromones: synthesis and control of biological activity. Peptides 25:1377-1388.
12. Corby, P. M., J. Lyons-Weiler, W. A. Bretz, T. C. Hart, J. A. Aas, T. Boumenna, J. Goss, A. L. Corby, H. M. Junior, R. J. Weyant, and B. J. Paster. 2005. Microbial risk indicators of early childhood caries. J. Clin. Microbiol. 43:5753-5759.
13. Dirix, G., P. Monsieurs, B. Dombrecht, R. Daniels, K. Marchal, J. Vanderleyden, and J. Michiels. 2004. Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide in silico screening for peptides containing a double-glycine leader sequence and their cognate transporters. Peptides 25:1425-1440.
14. Donlan, R. M., and J. W. Gosterton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
15. Eckert, R., F. Qi, D. K. Yarbrough, J. He, M. H. Anderson, and W. Shi. 2006. Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob. Agents Chemother. 50:1480-1488.
16. Fischer, R., O. Mader, G. Jung, and R. Brock. 2003. Extending the applicability of carboxyfluorescein in solid-phase synthesis. Bioconjug. Chem. 14:653-660.
17. Fux, C. A., P. Stoodley, L. Hall-Stoodley, and J. W. Costerton. 2003. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti-Infect. Ther. 1:667-683.
18. Gilmour, M. N., T. S. Whittam, M. Kilian, and R. K. Selander. 1987. Genetic relationships among the oral streptococci. J. Bacteriol. 169:5247-5257.
19. Huang, M. Y., and J. H. Wang. 2003. Impact of antibiotic use on fungus colonization in patients hospitalized due to fever. J. Microbiol. Immunol. Infect. 36:123-128.
20. Keene, H. J., and I. L. Shklair. 1974. Relationship of Streptococcus mutans carrier status to the development of carious lesions in initially cariesfree recruits. J. Dent. Res. 53:1295.
21. Kleerebezem, M., L. E. Quadri, O. P. Kuipers, and W. M. de Vos. 1997. Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Mol. Microbiol. 24:895-904.
22. Kreth, J., J. Merritt, W. Shi, and F. Qi. 2005. Co-ordinated bacteriocin production and competence development: a possible mechanism for taking up DNA from neighbouring species. Mol. Microbiol. 57:392-404.
23. Li, Y. H., P. C. Lau, J. H. Lee, R. P. Ellen, and D. G. Cvitkovitch. 2001. Natural genetic transformation of Streptococcus mutans growing in biofilms. J. Bacteriol. 183:897-908.
24. Loesche, W. J. 1986. The identification of bacteria associated with periodontal disease and dental caries by enzymatic methods. Oral Microbiol. Immunol. 1:65-72.
25. Loesche, W. J. 1986. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 50:353-380.
26. Loesche, W. J., A. Walenga, and P. Loos. 1973. Recovery of Streptococcus mutans and Streptococcus sanguis from a dental explorer after clinical examination of single human teeth. Arch. Oral. Biol. 18:571-575.
27. Mandel, I. D. 1988. Chemotherapeutic agents for controlling plaque and gingivitis. J. Clin. Periodontol. 15:488-498.
28. Marsh, P., and M. V. Martin. 1999. Oral microbiology, 4th ed. Wright, Oxford, United Kingdom.
29. Merritt, J., J. Kreth, F. Qi, R. Sullivan, and W. Shi. 2005. Non-disruptive, real-time analyses of the metabolic status and viability of Streptococcus mutans cells in response to antimicrobial treatments. J. Microbiol. Methods 61:161-170.
30. Merritt, J., F. Qi, and W. Shi. 2005. A unique nine-gene comY operon in Streptococcus mutans. Microbiology 151:157-166.
31. Mikx, F. H., J. S. Van Der Hoeven, A. J. Plasschaert, and K. G. Konig. 1975. Effect of Actinomyces viscosus on the establishment and symbiosis of Streptococcus mutans and Streptococcus sanguis in SPF rats on different sucrose diets. Caries Res. 9:1-20.
32. Mitchell, T. J. 2003. The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat. Rev. Microbiol. 1:219-230.
33. Otto, M. 2001. Staphylococcus aurais and Staphylococcus epidermidis peptide pheromones produced by the accessory gene regulator agr system. Peptides 22:1603-1608.
34. Perron, G. G., M. Zasloff, and G. Bell. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273:251-256.
35. Pickard, K. M., A. R. Bremner, J. N. Gordon, and T. T. MacDonald. 2004. Microbial-gut interactions in health and disease. Immune responses. Best Pract. Res. Clin. Gastroenterol. 18:271-285.
36. Pultz, N. J., C. K. Hoyen, and C. J. Donskey. 2004. Inhibition of methicillin-resistant Staphylococcus aurais by an in vitro continuous-flow culture containing human stool microflora. FEMS Microbiol. Lett. 241:201-205.
37. Qi, F., J. Kreth, C. M. Levesque, O. Kay, R. W. Mair, W. Shi, D. G. Cvitkovitch, and S. D. Goodman. 2005. Peptide pheromone induced cell death of Streptococcus mutans. FEMS Microbiol. Lett. 251:321-326.
38. Qiu, X. Q., J. Zhang, H. Wang, and G. Y. Wu. 2005. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 49:1184-1189.
39. Qiu, X. Q., H. Wang, X. F. Lu, J. Zhang, S. F. Li, G. Cheng, L. Wan, L. Yang, J. Y. Zuo, Y. Q. Zhou, H. Y. Wang, X. Cheng, S. H. Zhang, Z. R. Ou, Z. C. Zhong, J. Q. Cheng, Y. P. Li, and G. Y. Wu. 2003. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria. Nat. Biotechnol. 21:1480-1485.
40. Rastall, R. A. 2004. Bacteria in the gut: friends and foes and how to alter the balance. J. Nutr. 134:2022S-2026S.
41. Rhee, K. J., P. Sethupathi, A. Driks, D. K. Lanning, and K. L. Knight. 2004. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 172:1118-1124.
42. Rhee, K. Y., R. Soave, and C. Malta. 2004. Methicillin-resistant Staphylococcus aureus as a cause of antibiotic-associated diarrhea. J. Clin. Gastroenterol. 38:299-300.
43. Rogers, A. H. 1975. Bacteriocin types of Streptococcus mutans in human mouths. Arch. Oral Biol. 20:853-858.
44. Sansonetti, P. J. 2004. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4:953-964.
45. Stewart, P. S. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 292:107-113.
46. Stewart, P. S., and J. William Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
47. Tlaskalova-Hogenova, H., R. Stepankova, T. Hudcovic, L. Tuckova, B. Cukrowska, R. Lodinova-Zadnikova, H. Kozakova, P. Rossmann, J. Bartova, D. Sokol, D. P. Funda, D. Borovska, Z. Rehakova, J. Sinkora, J. Hofman, P. Drastich, and A. Kokesova. 2004. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 93:97-108.
48. Walker, C. B. 1988. Microbiological effects of mouthrinses containing antimicrobials. J. Clin. Periodontol. 15:499-505.